Y-Biologics, Inc. (KOSDAQ:338840)
South Korea
· Delayed Price · Currency is KRW 26,150
-2,000 (-7.10%)
At close: Dec 5, 2025
Y-Biologics Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Cash & Equivalents | 444.33 | 9,083 | 20,535 | 12,614 | 16,873 | 33,389 | Upgrade
|
| Short-Term Investments | 41,744 | 3,120 | 362.11 | 368.9 | 74.96 | - | Upgrade
|
| Trading Asset Securities | 84.58 | - | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 42,273 | 12,204 | 20,898 | 12,983 | 16,948 | 33,389 | Upgrade
|
| Cash Growth | 200.20% | -41.60% | 60.97% | -23.40% | -49.24% | 30.85% | Upgrade
|
| Accounts Receivable | 194.93 | 63.87 | 573.37 | 689.88 | 825.19 | 247.65 | Upgrade
|
| Other Receivables | 57.64 | 27.78 | 21.97 | 0.67 | 317.93 | 107.58 | Upgrade
|
| Receivables | 252.56 | 91.64 | 595.34 | 690.55 | 1,143 | 355.23 | Upgrade
|
| Prepaid Expenses | 74.61 | 42.91 | 89.29 | 20.2 | 91.4 | 17.49 | Upgrade
|
| Other Current Assets | 263.88 | 132.56 | 180.33 | 845.17 | 1,663 | 4,323 | Upgrade
|
| Total Current Assets | 42,864 | 12,471 | 21,763 | 14,538 | 19,845 | 38,085 | Upgrade
|
| Property, Plant & Equipment | 6,462 | 7,407 | 8,009 | 10,801 | 16,824 | 10,331 | Upgrade
|
| Long-Term Investments | 344.43 | - | - | - | - | - | Upgrade
|
| Other Intangible Assets | 365.64 | 223.37 | 247.18 | 316.56 | 279.35 | 349.01 | Upgrade
|
| Other Long-Term Assets | 1,512 | 1,627 | 275.5 | 3,667 | 1,296 | 971.33 | Upgrade
|
| Total Assets | 51,548 | 21,727 | 30,294 | 29,323 | 38,245 | 49,736 | Upgrade
|
| Accounts Payable | 2.12 | 3.23 | 1.21 | - | - | - | Upgrade
|
| Accrued Expenses | 194.69 | 243.31 | 205.33 | 224.38 | 352.99 | 190.42 | Upgrade
|
| Short-Term Debt | 18,985 | - | 2,000 | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | - | 500 | - | 4,528 | 2,336 | - | Upgrade
|
| Current Portion of Leases | 103.18 | 153.57 | 192.47 | 223.39 | 516.5 | 250.91 | Upgrade
|
| Other Current Liabilities | 17,653 | 262 | 508.83 | 3,569 | 3,003 | 9,647 | Upgrade
|
| Total Current Liabilities | 36,938 | 1,162 | 2,908 | 8,545 | 6,209 | 10,089 | Upgrade
|
| Long-Term Debt | - | - | 500 | - | 2,528 | 4,864 | Upgrade
|
| Long-Term Leases | 59.1 | 125.19 | 200.01 | 188.1 | 574.62 | 232.97 | Upgrade
|
| Other Long-Term Liabilities | 778.84 | 802.45 | 677.72 | 645.96 | 491.76 | 345.83 | Upgrade
|
| Total Liabilities | 37,776 | 2,090 | 4,286 | 9,379 | 9,803 | 15,532 | Upgrade
|
| Common Stock | 7,475 | 7,391 | 7,381 | 6,145 | 6,141 | 5,763 | Upgrade
|
| Additional Paid-In Capital | 126,304 | 124,295 | 122,727 | 93,385 | 93,287 | 79,550 | Upgrade
|
| Retained Earnings | -127,201 | -120,290 | -113,849 | -92,978 | -74,173 | -57,102 | Upgrade
|
| Comprehensive Income & Other | 7,195 | 6,960 | 7,149 | 5,741 | 3,186 | 2,320 | Upgrade
|
| Total Common Equity | 13,772 | 18,356 | 23,408 | 12,293 | 28,441 | 30,530 | Upgrade
|
| Shareholders' Equity | 13,772 | 19,637 | 26,008 | 19,943 | 28,441 | 34,205 | Upgrade
|
| Total Liabilities & Equity | 51,548 | 21,727 | 30,294 | 29,323 | 38,245 | 49,736 | Upgrade
|
| Total Debt | 19,147 | 778.76 | 2,892 | 4,940 | 5,955 | 5,348 | Upgrade
|
| Net Cash (Debt) | 23,126 | 11,425 | 18,005 | 8,043 | 10,992 | 28,041 | Upgrade
|
| Net Cash Growth | 73.71% | -36.55% | 123.86% | -26.83% | -60.80% | 39.85% | Upgrade
|
| Net Cash Per Share | 1557.05 | 764.89 | 1438.09 | 654.40 | 903.42 | 2810.07 | Upgrade
|
| Filing Date Shares Outstanding | 14.97 | 14.78 | 14.76 | 12.29 | 12.17 | 9.98 | Upgrade
|
| Total Common Shares Outstanding | 14.97 | 14.78 | 14.76 | 12.29 | 12.17 | 9.98 | Upgrade
|
| Working Capital | 5,926 | 11,309 | 18,855 | 5,993 | 13,636 | 27,997 | Upgrade
|
| Book Value Per Share | 920.23 | 1241.72 | 1585.65 | 1000.22 | 2337.50 | 3059.56 | Upgrade
|
| Tangible Book Value | 13,407 | 18,132 | 23,161 | 11,977 | 28,162 | 30,181 | Upgrade
|
| Tangible Book Value Per Share | 895.80 | 1226.61 | 1568.90 | 974.46 | 2314.54 | 3024.59 | Upgrade
|
| Land | 749.16 | 749.16 | 594.79 | 594.79 | 594.79 | 594.79 | Upgrade
|
| Buildings | 4,326 | 4,326 | 3,370 | 3,370 | 3,370 | 3,370 | Upgrade
|
| Machinery | 10,714 | 10,580 | 10,479 | 12,144 | 11,635 | 5,245 | Upgrade
|
| Construction In Progress | 353.61 | 317.23 | 377.82 | 301.48 | 3,703 | 3,556 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.